March 22, 2011
/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage vaccine company, announced today that Dr.
, President and Chief Executive Officer of Novavax, will give a keynote address at the 3rd World Congress of Vaccine on
March 23rd, 2011
at the China National Convention Center in
. Dr. Singhvi will be giving a presentation on Commercialization Strategies for Vaccines in Emerging Markets. In addition,
, Senior VP - Business Development, will also give a presentation at the conference titled, The Value of Government Alliances for Effective Pandemic Preparedness.
Novavax, Inc. (Nasdaq: NVAX), a clinical-stage biopharmaceutical company, employs its cutting-edge technology to create next-generation vaccines to prevent serious infectious diseases, such as pandemic and seasonal influenza and respiratory syncytial virus (RSV). The company's proprietary virus-like particles (VLPs) technology and single-use bioprocessing system enables rapid vaccine development and production where and when it's needed, worldwide. The company has formed a joint venture with Cadila Pharmaceuticals, named CPL Biologicals, to develop and manufacture vaccines, biological therapeutics and diagnostics in
. Additional information about Novavax is available on the company's website:
SOURCE Novavax, Inc.